- Home
- CSTE vs ABVC Comparison
CSTE vs ABVC Comparison
Compare CSTE & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSTE | ABVC |
|---|---|---|
| Founded | 1987 | 2015 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.2M | 58.6M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | CSTE | ABVC |
|---|---|---|
| Price | $2.23 | $2.08 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 92.3K | 62.8K |
| Earning Date | 03-04-2026 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $400,656,000.00 | $797,916.00 |
| Revenue This Year | N/A | $735.18 |
| Revenue Next Year | $1.59 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 56.52 |
| 52 Week Low | $0.86 | $0.40 |
| 52 Week High | $4.67 | $5.48 |
Technical Indicators
Market Signals| Indicator | CSTE | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 66.39 | 40.58 |
| Support Level | $1.95 | $1.98 |
| Resistance Level | $2.16 | $2.20 |
| Average True Range (ATR) | 0.19 | 0.14 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 84.85 | 17.02 |
Price Performance
Historical ComparisonAbout CSTE Caesarstone Ltd.
Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.